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ABSTRACT
Objective: To study the antilithiatic activity of ethanolic extract of leaves of Cissampelos pareira (EELCP) in 2% ammonium chloride (AC) and 0.75% 
ethylene glycol (EG) induced urolithiasis in albino rats.
Methods: Kidney stones were induced in rats by feeding drinking water mixed with 2% (AC) and 0.75% (EG) for 10 days. Stones were confirmed by 
the increased urinary levels of calcium, uric acid and decreased levels of magnesium and increased levels of serum creatinine and calcium. The rats 
were treated with 03 doses of EELCP i.e. 100 mg/kg, 200 mg/kg, 400 mg/kg respectively, orally in different groups of albino rats once daily for 10 days 
along with 2% (AC) and 0.75% (EG) containing drinking water. On 11th day, 3 rats from each group were kept in one metabolic cage and urine (pooled) 
collected for 24 hrs was subjected for assessment of various biochemical parameters. Blood was collected on the same day and analyzed for various 
parameters. Kidneys were observed for the histopathological changes.
Results: Rats treated with 03 doses of EELCP significantly (p≤0.05) decreases the urinary calcium, uric acid and enhanced urinary magnesium levels, 
decreased serum calcium, creatinine and enhanced serum magnesium. Histopathology of kidneys in groups treated with EELCP at 200 mg/kg and 
400 mg/kg doses revealed less tissue damage and the cytology of nephrotic tissue was almost similar to the control Group I rats.
Conclusion: Results showed EELCP has shown significant antilithiatic effect against chemical induced urolithiasis in rats.
Keywords: Cissampelos pareira, Leaf extract, Antilithiatic activity, Urolithiasis, Ethylene glycol.
INTRODUCTION
Urolithiasis is defined as the formation of urinary calculi or the condition 
associated with urinary calculi. Urolithiasis is the third most common 
disorder of the urinary tract. Cases of urinary calculi are present worldwide, 
but are particularly common in some geographic locales such as in parts of 
United States, India, South Africa, and South East Asia. It is estimated that 
around 2% of the world population experiences renal calculi at sometime 
in the lifespan with a male-female ratio of 2:1. The peak occurrence 
is observed in 2nd-3rd decade of life. Kidney stones were characterized 
clinically by colicky pain as they pass down along the ureter, and 
noticeable by hematuria. Risk factors accountable for the nephrolithiasis 
are insufficient urinary drainage, microbial infections, food with excess 
oxalates and calcium, vitamin abnormalities i.e., deficiency of vitamin A, 
excess of vitamin D, metabolic diseases like hyperparathyroidism, 
cystinuria, gout, intestinal dysfunction [1] and environmental factors 
related to regions with hot and dry climatic conditions [2]. In spite of 
various advantages and several methods available for the treatment 
of urolithiasis in the allopathic system of medicine, it suffers from little 
disadvantages that compel the patients to other forms of medicine like 
Ayurveda, Homeopathy, Unani, Folklore medicine etc. Vast number of 
medicinal plants mentioned in ayurvedic system of medicine are known 
to possess antiurolithic properties, some of the antiurolithic agents are 
derived from medicinal plants such as of Cissampelos pareira, Onosma 
bracteatum, Lanata camara, Pinus eldarica, Pergularia daemia, Cynodon 
dactylon, Hordeum vulgare, Didymocarpus pedicellata, Saxifraga ligulata, 
Rubia cordifolia, Cyperus scariosus, Achyranthes aspera, Vernonia cinerea 
and herbomineral preparations Shilajeet and Hajrul yahood bhasmas etc.
Plant description
The C. pareira [3], an extensively spreading, glabrous to soft pubescent, 
perennial climbing shrub found all over, India and is commonly known as 
Padha and other synonyms are Padvel, Padvali, Poda, Aaknadi, Venievel, 
and Patha belongs to the family of Menispermaceae [3]. In Ayurvedic 
system of medicine, the leaves and roots are used in the treatment of 
indolent ulcers (Kirtikar and Basu, 2001) and diarrhea (Amresh et al., 
2003). The plant is used in the treatment of urinary tract infections 
since, it is considered as antiseptic (Dandiya and Chopra, 1970). Juice 
of C. pareira is given in migraine, and the plant has a long history of 
use for inflammation of muscles, snakebite, rheumatism, diarrhea, 
dysentery and menstrual problems. C. pareira is widely employed 
in herbal medicine today as a diuretic, tonic as well as to reduce 
fever and to relieve pain. It is often employed for menstrual cramps, 
dysmenorrhoea, excessive bleeding and uterine hemorrhages, fibroid 
tumors, pre and post natal pain, colic, constipation, poor digestion and 
dyspepsia. Hence, midwives in Amazon always carry the C. pareira for 
the above mentioned ailments (Mukerji and Bhandari, 1959).
Some scientific studies revealed its antinociceptive [4], antiarthritic [4], 
cardiotonic [5], anticancer [6], anti-inflammatory [7], antidiarrheal [8], 
anti-hemorrhagic, antifertility [9], antioxidant, neuroprotective [10], 
hepatoprotective [11], antioxidant [12], immunomodulatory [12], 
antiurolithic, [13] anti trypanosomal activities. The major constituents 
of roots of C. pareira include [14] pelosin, O-methylcurine, l-curine 
cissamine, cissampareine, Hyatin, bebeerine, cycleanine, tetrandine 
and beriberine, cissampeline, cissampoline, dicentrine, insularine, 
pareirine, hyatinine, pareirubrine A, pareirubrine B, pareitropone, 
norimeluteine, cissampeloflavone, D-quercitol and grandirubrine [15]. 
The leaves of C. pareira are traditionally used as a antilithiatic but 
scientifically not evaluated as a antiurolithic agent. The main aim of the 
present study was to evaluate antilithiatic activity of leaves of C. pareira 
in ammonium chloride (AC) (2%) and (0.75%) ethylene glycol (EG) 
induced urolithiasis in albino rats.
METHODS
Collection of plant
The leaves of C. pareira were collected from the forest of Tirupati, 
Andhra Pradesh, and were identified and authenticated by Dr. Pramod 
Kumar, Pharmacognocist V. L. College of Pharmacy, Raichur, Karnataka.
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Preparation of extract
Leaves were thoroughly washed under fresh tap water, and shade dried 
and powdered using a mechanical grinder. The ethanolic extract of 
leaves of C. pareira (EELCP) was prepared by soxhletation. About 200 g 
of leaves powder was taken into the soxhlet apparatus, and extracted 
using (95%) ethanol. The extraction process was carried out for 
18-20 hrs till the appearance of the colorless solvent in the side tube. 
The extract collected was dried by evaporating the solvents on a water 
bath maintained at <50°C and percentage yield of EELCP was recorded 
with respect to the total quantity of powder used for the extraction. 
Then the extract was evaluated for its phytochemicals by following 
standard procedures [15].
Experimental animals
Male Albino rats (36) weighing between 140 and 200 g used in the 
study (6 groups; n=6) were obtained from the Central Animal House, 
V. L. College of Pharmacy, Raichur, Karnataka. The experimental 
protocol was approved by the Institutional Animal Ethical Committee 
(IAEC). The animals were maintained under standard husbandry 
conditions temperature 22±2°C, humidity 45-55%, light:Dark cycle 
(12:12 hrs) for an acclimatization period of 15 days before performing 
the experiments. All rats were placed in metallic cages three in each.
Ethics
The experiments compiled with the guidelines for animal 
experimentation of our laboratory, and were approved by the IAEC, 
VLCP, Raichur.
Drugs and chemicals used
Cystone 5 ml/kg (Himalaya Drug Company, Bangalore, India.), EG 
(S. D Fine Chemicals, Hyderabad, Andhra Pradesh, India), AC (S. D Fine 
Chemicals, Hyderabad, Andhra Pradesh, India), CMC (S. D Fine 
Chemicals, Hyderabad, Andhra Pradesh, India).
Acute toxicity study
Determination of LD50: The acute toxicity [16,17] of EELCP was 
determined using albino mice of either sex (16-20 g), maintained 
under standard husbandry conditions. The animals were fasted for 
3 hrs prior to the experiment, and the extract was administered as a 
single dose and observed for the mortality up to 48 hrs study period 
(short term toxicity). Based on the short term toxicity profile, the next 
dose of the extract was determined as per OECD guidelines No.420 up-
to the maximum dose level of 2000 mg/kg. From the LD50, dose of the 
individual extract, doses like 1/20
th, 1/10th and 1/5th were selected and 
considered as low, medium and high dose i.e.: 100 mg/kg, 200 mg/kg, 
400 mg/kg respectively to carry out this study.
Experimental design
The antilithiatic activity of EELCP in albino rats was studied in AC (2% 
AC) and (0.75%) EG induced urolithiasis [18-20]. Healthy male albino 
rats weighing between 140 and 200 g were randomly divided into 
06 groups with each consisting of six animals and the treatment with 
AC, EG mixed water was continued for 10 days.
Group-I: Fed with standard rat chow diet and tap water only ad libitum 
for 10 days.
Group-II: Fed with normal rat diet + drinking water containing 0.75% 
EG v/v + 2% AC w/v for 10 days to induce urolithiasis.
Group-III: Fed with normal rat diet + drinking water containing 0.75% v/v 
EG + 2% w/v AC + standard drug cystone (5 ml/kg) for 10 days.
Group-IV: Fed with normal rat diet + drinking water containing 0.75% v/v 
EG + 2% w/v AC with EELCP lower dose (100 mg/kg) for 10 days.
Group-V: Fed with normal rat diet + drinking water containing 
0.75% v/v EG + 2% w/v AC with EELCP medium dose (200 mg/kg) for 
10 days.
Group-VI: Fed with normal rat diet + drinking water containing 0.75% v/v 
EG + 2% w/v AC with EELCP high dose (400 mg/kg) for 10 days.
Collection and analysis of urine
On 11th day, 3 rats from each group were kept in single metabolic 
cage and urine (pooled) collected for 24 hrs. HCl was added to the 
urine before being stored at 4°C. Urine was measured for volume and 
analyzed for biochemical parameters i.e.,; calcium, magnesium and uric 
acid.
Serum analysis
Blood was also collected on 11th day by retro orbital puncture 
under ether anesthesia, and the animals were sacrificed by cervical 
decapitation. Serum was separated by centrifugation at 10,000 rpm for 
10 minutes and analyzed for calcium, magnesium and creatinine.
Histopathological studies
Kidneys collected from rats were weighed individually, and fixed 
rapidly with 10% formalin. This sections of kidneys fixed in paraffin 
were prepared and stained with eosin and hematoxylin and observed 
for histopathological changes.
Statistical analysis
Experimental results were expressed as mean±standard error of the 
mean (n=6). Statistical analysis was performed with one way ANOVA 
followed by Dunnetts t-test by using Graph Pad Prism software 
version 5.00.
RESULTS
The EELCP was subjected to qualitative phytochemical tests to 
identify the phytoconstituents, and the tests revealed the presence 
of carbohydrates, alkaloids, sterols, phenolic compounds, tannins, 
flavonoids and resins.
In acute toxicity study, all the animals were survived even after 14 days 
indicates the non toxicity of the extract even up to the maximum 
permitted dose level of 2000 mg/kg. No major behavioral changes were 
observed during this period of study.
The results obtained with antilithiatic activity studies with EELCP was 
shown in Table 1. From the results when compared to normal control 
it can be observed that EELCP has shown a considerable antilithiatic 
activity by enhancing urinary output, magnesium and decreasing 
calcium, uric acid and decreasing serum creatinine, calcium and 
increasing magnesium levels. The antilithiatic effect observed after 
treatment with EELCP was found to be significant and comparable 
to standard drug cystone in terms of increase in urinary output and 
reduction in the tendency for crystallization.
The rats treated with EELCP at doses 100 mg/kg, 200 mg/kg and 
400 mg/kg significantly (p≤0.05) reduced serum calcium and creatinine 
but increased magnesium. Further urinary calcium, uric acid levels 
were significantly decreased but urinary magnesium increased (Fig. 1).
In Group-I histopathology of kidneys revealed no calcium oxalate (Ca Ox) 
deposits or other abnormalities in the nephron segment. In lithiatic 
rats (Group-II) several Ca Ox crystal deposits inside the tubules and 
dilation of the proximal tubules along with interstitial inflammations 
and degeneration of epithelial cells were observed in the renal tissue. 
The groups treated with EELCP (Groups IV-VI) and cystone treated rats 
(Group III) the number of Ca Ox deposits in the tubules were less than 
Group II. In groups treated with EELCP at 200 mg/kg and 400 mg/kg 
dose levels revealed less tissue damage and the cytology of the nephrotic 
tissue was almost similar to Group I (normal) control rats (Fig. 1).
DISCUSSION
Pathological diseases of kidney including Ca Ox renal stones, have 
resulted due to the oxalate-induced damage to the renal cells [21,22]. 
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Enhanced levels of oxalate are accountable for the toxic effects on the 
renal epithelial cells via alteration in membrane integrity, production 
of reactive oxygen species and minimal resource of antioxidant 
enzymes [23,24]. In the present study, male rats were selected to induce 
urolithiasis because their urinary system resembles that of humans [25].
In view of its traditional use in renal stones, C. pareira leaves extract 
was studied to screen its potential as antiurolithic agent in (AC 2%) 
AC and (0.75%) EG induced urolithiasis. This is the first kind of the 
scientific work for the first time studied to show the antiurolithiatic 
effect of EELCP in urolithiasis model.
From the results, it was noted that EELCP shown curative effect in 
urolithiasis induced rats by preventing the formation, decreasing 
number and disruption of Ca Ox stone formed in the kidneys. The 
basis for calcium stone formation is super saturation of urine with 
stone-forming calcium salts. A number of dietary factors and metabolic 
abnormalities can alter the saturation of the urine that increases stone-
forming property. Among the metabolic conditions are hypercalciuria, 
hyperoxaluria and hypocitraturia.
Renal Ca Ox deposition induced by AC and EG in rats is commonly 
used as a model to mimic the urinary stone development in humans 
(Thamilselvan et al., 1997; Atmani et al., 2003; Tsai et al., 2008). Thus, 
this model was used to screen the possible antilithiatic effect of EELCP 
on Ca Ox urolithiasis.
In the present study, EELCP treated rats exhibited enhanced urinary 
output, which dilutes the urinary electrolytes concentration. As a result, 
calcium and uric acid are flush out via the urine leaving a lesser possibility 
of precipitation with a reduced formation as well as the growth of 
urinary calculi. The elimination of calcium and uric acid were gradually 
increased in stone induced rats that are in accordance with the previous 
reports [26]. Most calculi in the urinary system come up from a common 
component of urine such as Ca Ox and hypercalciuria, indicating up to 
80% of analyzed stones [27]. Enhanced urinary calcium facilitates the 
nucleation and precipitation of Ca Ox from urine and subsequent crystal 
growth [28]. However, EELCP reduced the levels of calcium as well as 
uric acid, which is helpful in preventing calculi formation.
Calcium oxalate crystal development is facilitated by uric acid either 
by direct induction of Ca Ox precipitation by colloidal uric acid [29] or 
by acting as promoter by binding to glycosaminoglycans, and thereby 
decreasing their inhibitory activity against Ca Ox crystallization.
Magnesium strongly inhibits the crystallization of Ca Ox in vitro, 
magnesium attaches to oxalate to form a soluble complex, consequently 
decreasing the concentration available for Ca Ox precipitation [30]. Low 
urinary magnesium content is a common feature in stone formers [31]. 
Experiments in animal models have shown increased levels of 
magnesium offers protection against Ca Ox deposition in kidneys, 
but clinical studies have not shown any such beneficial effects in 
impeding the formation of Ca Ox kidney stones. Treatment with EELCP 
significantly enhanced the levels of magnesium in urine and serum but 
significantly decreased in EG and AC treated (Group-II) animals.
In the present work, EELCP was studied for its antilithiatic activity. 
The phytochemical studies reveal that the leaves of C. pareira contains 
flavonoids, alkaloids, carbohydrates, sterols, phenolic compounds. From 
the previous studies, it has been reported that flavonoids [13,32-35] 
alkaloids [13,35], saponins have antilithiatic activity. Previous studies 
reported phytochemical substances like flavonoids, saponins, organic 
acids, steroids, carbohydrates, phenolic compounds, terpenoids, 
alkaloids, glycosides, sterols, sesquiterpenes and aminoacids, 
carotinoids in different plant extracts. EERCP was identified with most 
of these phytochemical substances mentioned above. Hence, it can be 
reported that the observed antilithiatic activity is due to these above 
phytoconstituents.
CONCLUSION
Results exhibited that EELCP have shown a considerable protective effect 
(antilithiatic) against renal stone producing agents. Phytoconstituent 
like berberine is already reported for its antilithiatic activity. Berberine 
is an important bioactive constituent present in C. pareira. So here 
benzyl isoquinoline alkaloid berberine is responsible for antilithiatic 
activity because it was therapeutically effective for both prevention 
as well as curative aspect of Ca Ox urolithiasis, exhibiting these 
effects through a combination of antioxidant, diuretic, hypocalciuric, 
hypermagnesiemia and urine alkalanizing activities. Thus, the present 
study supports and rationalizes the basis for traditional use of leaves of 
C. pareira for antilithiatic activity.
Table 1: Effect of EELCP on urine volume, urinary calcium, uric acid, magnesium, and serum calcium, creatinine, magnesium in AC (2%) 
and EG (0.75%) induced urolithiasis













1 Normal control 14.30±0.02 0.47±0.01 7.80±0.01 1.95±0.01 7.24±0.02 4.31±0.04 5.61±0.03
2 Toxicant 5.51±0.03 1.52±0.02 5.10±0.02 0.73±0.01 15.69±0.01 1.34±0.03 14.59±0.03
3 Standard 13.25±0.03*** 0.59±0.01*** 8.04±0.03*** 1.86±0.02*** 9.27±0.03*** 3.59±0.04*** 7.80±0.03***
4 EELCP 100 mg/kg+EG plus AC 6.80±0.02*** 1.43±0.06*** 13.47±0.04*** 1.12±0.02*** 14.49±0.02*** 1.36±0.03*** 14.21±0.03***
5 EELCP 200 mg/kg+EG plus AC 8.76±0.03*** 1.34±0.01*** 11.54±0.02*** 1.20±0.02*** 12.43±0.03*** 1.59±0.03*** 11.07±0.03***
6 EELCP 400 mg/kg+EG plus AC 11.84±0.02*** 1.04±0.01*** 9.76±0.04*** 1.43±0.01*** 10.10±0.03*** 2.04±0.04*** 9.81±0.05***
Values expressed as mean±SEM, n=6, Significance at p<0.05*, p<0.01**, and p<0.001***. EELCP: Ethanolic extract of leaves of Cissampelos pareira, AC: Ammonium 
chloride, EG: Ethylene glycol, SEM: Standard error of the mean
Fig. 1: (a-f) Histopathology of kidneys with ammonium chloride 







Asian J Pharm Clin Res, Vol 7, Issue 5, 2014, 103-106
 Sayana et al. 
106
 REFERENCES
1. Tiselius HG. Etiology and investigation of stone disease. Curriculum in 
urology. Eur J Urol 1998;2(1):1-7.
2. Ramesh C, Nandakumar K, Rajesh R. Antiurolithic activity of heart wood 
extract of Cedrus deodara in rats. J Complement Integr Med 2010;7(1):11.
3. Agrawal SS, Tamrakar BP, Paridhavi M. Clinically Useful Herbal 
Drugs. 1st ed. New Delhi: Ahuja Publishers; 2009. p. 76.
4. Amresh G, Singh PN, Rao ChV. Antinociceptive and antiarthritic activity 
of Cissampelos pareira roots. J Ethnopharmacol 2007 22;111:531-6.
5. Singh BK, Pillai KK, Kohli K, Haque SE. Effect of Cissampelos pareira 
root extract on isoproterenol-induced cardiac dysfunction. J Nat Med 
2013;67(1):51-60.
6. Issat T, Jakóbisiak M, Golab J. Berberine, a natural cholesterol reducing 
product, exerts antitumor cytostatic/cytotoxic effects independently 
from the mevalonate pathway. Oncol Rep 2006;16:1273-6.
7. Amresh G, Reddy GD, Rao ChV, Singh PN. Evaluation of anti-
inflammatory activity of Cissampelos pareira root in rats. 
J Ethnopharmacol 2007;110:526-31.
8. Amresh, Reddy GD, Rao CV, Shirwaikar A. Ethnomedical value of 
Cissampelos pareira extract in experimentally induced diarrhoea. Acta 
Pharm 2004;54(1):27-35.
9. Ganguly M, Kr Borthakur M, Devi N, Mahanta R. Antifertility activity 
of the methanolic leaf extract of Cissampelos pareira in female albino 
mice. J Ethnopharmacol 2007;111:688-91.
10. Ye M, Fu S, Pi R, He F. Neuropharmacological and pharmacokinetic 
properties of berberine: A review of recent research. J Pharm Pharmacol 
2009;61(7):831-7.
11. Surendran S, Eswaran MB, Vijayakumar M, Rao CV. In vitro and 
in vivo hepatoprotective activity of Cissampelos pareira against 
carbon-tetrachloride induced hepatic damage. Indian J Exp Biol 
2011;49(12):939-45.
12. Bafna A, Mishra S. Antioxidant and immunomodulatory activity 
of the alkaloidal fraction of Cissampelos pareira linn. Sci Pharm 
2010;78(1):21-31.
13. Sayana SB, Khanwelkar CC, Nimmagadda VR, Chavan VR, Bh R, 
S NK. Evalution of antiurolithic activity of alcoholic extract of roots of 
Cissampelos pareira in albino rats. J Clin Diagn Res 2014;8(7):HC01-4.
14. Amritpal S, Sanjiv D, Jaswinder S, Shankar K. An inside preview 
of ethnopharmacology of Cissampelos pareira L. Int J Bio Technol 
2010;1(1):114-20.
15. Khandelwal KR. Practical Pharmacognosy Techniques and 
Experiments. 3rd ed. Pune: Nirali Prakashan; 2000. p. 149-56.
16. OECD. Guidelines on Acute Oral Toxicity. Environmental Health and 
Safety Monograph Series on Testing and Adjustment No.425; 2001.
17. Amresh G, Singh PN, Rao CV. Toxicological screening of traditional 
medicine Laghupatha (Cissampelos pareira) in experimental animals. 
J Ethnopharmacol 2008;116(3):454-60.
18. Suman KM, Satyaranjan M, Sahoo S, Panda PK. Antiurolithic activity of 
Crataeva magna Lour. bark. Indian J Nat Prod Resour 2011;2(1):28-33.
19. Choubey A, Choubey A, Jain P, Iyer D, Patil UK. Assessment of Ceiba 
pentandra on calcium oxalate urolithiasis in rats. Der Pharm Chem 
2010;2(6):144-56.
20. Khan A, Khan SR, Gilani AH. Studies on the in vitro and in vivo 
antiurolithic activity of Holarrhena antidysenterica. Urol Res 
2012;40(6):671-81.
21. Scheid CR, Koul HK, Kennington L, Hill WA, Luber-Narod J, 
Jonassen J, et al. Oxalate-induced damage to renal tubular cells. 
Scanning Microsc 1995;9(4):1097-105.
22. Kurien TB, Selvam R. Induction of lipid peroxidation in calcium 
oxalate stone formation. Indian J Exp Biol 1989;27(5):450-3.
23. Miller C, Kennington L, Cooney R, Kohjimoto Y, Cao LC, Honeyman T, 
et al. Oxalate toxicity in renal epithelial cells: Characteristics of 
apoptosis and necrosis. Toxicol Appl Pharmacol 2000;162(2):132-41.
24. Vermeulen CW. Essays in Experimental Biology. Chicago: University 
of Chicago Press; 1962. p. 253-69.
25. Richardson KE, Tolbert NE. Oxidation of glyoxylic acid to oxalic acid 
by glycolic acid oxidase. J Biol Chem 1961;236:1280-4.
26. Divakar K, Pawar AT, Chandrasekhar SB, Dighe SB, Divakar G. 
Protective effect of the hydro-alcoholic extract of Rubia cordifolia roots 
against ethylene glycol induced urolithiasis in rats. Food Chem Toxicol 
2010;48(4):1013-8.
27. Lemann J Jr, Worcester EM, Gray RW. Hypercalciuria and stones. Am 
J Kidney Dis 1991;17(4):386-91.
28. Low RK, Stoller ML. Uric acid-related nephrolithiasis. Urol Clin North 
Am 1997;24(1):135-48.
29. Srinivasan S, Kalaiselvi P, Sakthivel R, Pragasam V, Muthu V, 
Varalakshmi P. Uric acid: An abettor or protector in calcium oxalate 
urolithiasis? Biochemical study in stone formers. Clin Chim Acta 
2005;353(1-2):45-51.
30. Rushton HG, Spector M. Effects of magnesium deficiency on 
intratubular calcium oxalate formation and crystalluria in hyperoxaluric 
rats. J Urol 1982;127(3):598-604.
31. Khan SR. Animal models of kidney stone formation: An analysis. 
World J Urol 1997;15(4):236-43.
32. Mayee R, Thosar A. Evaluation of Lantana camara Linn for 
antiurolithiatic and antioxidant activities in rats. Int J Pharm Clin Res 
2011;3(6):10-4.
33. Khajavi Rad A, Hadjzadeh MA, Rajaei Z, Mohammadian N, 
Valiollahi S, Sonei M. The beneficial effect of Cynodon dactylon 
fractions on ethylene glycol-induced kidney calculi in rats. Urol J 
2011;8(3):179-84.
34. Touhami M, Laroubi A, Elhabazi K, Loubna F, Zrara I, Eljahiri Y, et al. 
Lemon juice has protective activity in a rat urolithiasis model. BMC 
Urol 2007;7:18.
35. Sayana SB, Khanwelkar CC, Nimmagadda VR, Chavan VR. 
Antiurolithic activity of aqueous extract of roots of Cissampelos 
pareira in albino rats. Asian J Pharm Clin Res 2014;7(3):49-53.
